In an environment of stricter pricing scrutiny, demands for transparency, and continued pricing pressure, manufacturers need to justify the value for innovation.
RE offers strategic consultation and advisory services to help manufacturers define and defend the value of innovation
Manufacturers have many stakeholders to consider when establishing price. Biopharma must learn to establish & communicate pricing to a broad stakeholder mix with different perspectives & needs.